Predicting the concentration level of an anti-cancer drug during treatment of a living organism

Medical Hypotheses

Volumn 60, Issue 4, 2003, Pages 498-500

  Moxnes, John F ^a   Hausken, Kjell ^b  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b UNIVERSITY OF STAVANGER   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITOXIN;

ARTICLE; CANCER CHEMOTHERAPY; DRUG BLOOD LEVEL; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SIMULATION; THEORETICAL MODEL;

EID: 0037375761     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00441-3     Document Type: Article

References (2)

1. Stenkvist B., Bengtsson E., Erikson O., Holmquist J., Nordin B., Westman-Naeser S. Cardiac glyco-sides and breast cancer. Lancet 1979; 1: 563.
2. Haux J., Lam M., Marthinsen A. B. L., Strickert T., Lundgren S. Digitoxin, in non toxic concentrations, induces apoptic cell death in Jurkat T cells in vitro. Originalia Z Onkol/J of Oncol 1999; 31(1): 14-20.